middle.news
How Tetratherix’s $5M Raise Fast-Tracks Tutelix Prostate Spacer Trials
9:32am on Tuesday 10th of March, 2026 AEDT
•
Healthcare
Read Story
How Tetratherix’s $5M Raise Fast-Tracks Tutelix Prostate Spacer Trials
9:32am on Tuesday 10th of March, 2026 AEDT
Key Points
Promising safety and efficacy results from initial Tutelix prostate spacer trial
Series A funding round led by MedTech VC raises ~$5 million
International pivotal trial planned in Australia and US targeting FDA clearance by 2028
Tutelix offers clinical advantages over existing spacers, including ultrasound visibility and flexible administration
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
TETRATHERIX (ASX:TTX)
OPEN ARTICLE